Engineered microvesicle-mediated multimodal therapy resolves ulcerative colitis via synergistic immunoregulation, barrier restoration, and microbiota remodeling
Cuihua Qi, Chaoyue Liang, Sha Wang, Hui Zhang, Han Wei, Xiaojun He, Weigang Chen · 2026
Read Engineered microvesicle-mediated multimodal therapy resolves ulcerative colitis via synergistic immunoregulation, barrier restoration, and microbiota remodeling by Cuihua Qi, Chaoyue Liang, Sha Wang, Hui Zhang, Han Wei, Xiaojun He, Weigang Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571736.txt.
Description
Cuihua Qi and co-authors wrote a study from 2026 on a therapy built from tiny sacs shed by immune cells, tested for a bowel disease. The disease, ulcerative colitis, inflames the large bowel, weakens its wall, and upsets its germ mix. Current drugs help only in part. The team shaped the sacs from a calm form of immune cell so they carry healing cargo.
In the disease model, the sacs eased weight loss, bleeding, and colon shrinkage. They also healed damage in the bowel wall and brought its barrier back. They cut the levels of three harsh swelling signals and raised a calming one, by blocking a known alarm path in cells. The bowel's germ mix grew richer and more balanced under the treatment. The team presents the sacs as a multi-part therapy that calms swelling, repairs the wall, and resets the germ mix at once.
Catalog record
| CREATOR | Cuihua Qi, Chaoyue Liang, Sha Wang, Hui Zhang, Han Wei, Xiaojun He, Weigang Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |